Thyroid disorder decisions — 2024

The Veteran's hypertension has been granted a 10 percent rating, but no higher. The issue of entitlement to a compensable rating for hypothyroidism is remanded due to inadequate examination.

The Veteran's hypothyroidism prior to June 19, 2019 is rated at 30 percent.

The Board denied the appellant's claim for special monthly pension (SMP) based on the need for aid and attendance or housebound status due to insufficient evidence showing she needed regular assistance, was bedridden, or housebound.

The Board has granted the Veteran's claim for service connection for thyroid nodules, finding that exposure to radiation during service is presumed and likely caused his current condition.

The Board has dismissed all claims due to the Veteran's death, as veterans' claims do not survive their deaths.

The Board has remanded the claims for clarification regarding the timing of a reported scud missile attack and to obtain further evidence on the relationship between sleep apnea, PTSD, and other conditions.

The Veteran's claim for service connection of hypothyroidism associated with Agent Orange exposure is granted, effective from May 8, 2023. The effective date was preserved as the claim was filed within one year of his intent to file a claim.

The Veteran's bilateral hearing loss and tinnitus are granted as service-connected.,Service connection is also granted for hypothyroidism, prostate cancer, and diabetes mellitus type II due to in-service herbicide exposure. Ischemic heart disease remains denied.

The Veteran's hypertension is granted with a 10% rating since November 28, 2018.,Service connection for thyroid disorder and right arm disorder are remanded due to insufficient evidence.

The Board has granted a 30 percent rating for residuals of thyroidectomy manifesting with constant abdominal distress and constipation, but the issue of compensation for thyroid cancer to include residuals, dysphagia is remanded due to incomplete VA examinations.

The Veteran's claims for service connection and increased ratings were denied as the effective dates sought are not earlier than October 5, 2021.,For issues related to service connection, the earliest date of entitlement is considered to be October 5, 2021.

The Board has remanded the case due to a failure to research Air Force Base histories from January 1968 to June 1971, which could have provided evidence of possible exposure to herbicide agents in Panama.

The Board has remanded the case due to incomplete evidence and the need for an addendum opinion regarding toxic exposure claims.

The Veteran's OSA is granted, but his right hand arthritis, peripheral neuropathy of the upper and lower extremities, lumbar spine disorder, and other conditions are denied. The AOJ must obtain a proper examination for the issues not yet addressed.

The Board has remanded the Veteran's claims for service connection for prostate cancer and thyroid cancer due to a lack of examination and dose assessment, as well as potential TERA exposure. The Veteran is seeking service connection based on his assertions of toxic exposure during active duty.

The Board has denied the Veteran's claims of service connection for residuals of right thyroid mass with tracheal deviation, status post total thyroidectomy and unspecified depressive disorder. The claim for sleep apnea (OSA) is remanded.

The Board has remanded the Veteran's claims for service connection for prostate cancer and thyroid cancer due to a lack of examination and dose assessment, as well as potential TERA exposure. The Veteran is seeking service connection based on new evidence.

The Board grants an effective date of July 27, 2019 for the award of service connection for hypothyroidism. The reduction from a 30% rating to noncompensable (0%) was found to be proper based on CUE.

The Veteran's appeal was dismissed due to his death, and the Board has no legal authority to adjudicate the merits of the claims at this time.

The Board has remanded the case due to a duty to assist error, specifically regarding the differentiation of symptoms attributable to service-connected hypothyroidism and nonservice-connected multiple sclerosis.